A genetically engineered anti-TNF compound (trade name Enbrel) consisting of receptors that bind TNF; it is injected twice a week in the treatment of rheumatoid arthritis
This website uses cookies to give you the best, most relevant experience. Using this website means you're Ok with this. More information can be found in our Privacy Policy page.